Twogee Biotech Raises €2.16M Seed Round to Convert Residual Biomass into Circular, Low-CO₂ Chemical Building Blocks

MUNICH, GERMANY | January 29, 2026

Twogee Biotech, a Munich-based industrial biotechnology startup, today announced it has raised €2.16 million in seed funding to commercialize its enzyme platform that converts residual biomass into sustainable, second-generation raw materials for the chemical industry.

The round was led by High-Tech Gründerfonds (HTGF) and Bayern Kapital, with participation from AgriFoodTech Venture Alliance and strategic investor Heinz Entsorgung.

Founded in 2024, Twogee Biotech develops customized enzyme solutions and production strains that enable industrial partners to transform underutilized biomass side streams, including agricultural residues and organic industrial by-products, into valuable chemical building blocks with significantly reduced CO₂ footprints.

Enabling Circular, Low-Emission Production

Twogee’s platform is designed to help chemical manufacturers and bio-based producers redesign material flows rather than incrementally optimize existing ones. By converting low-value residual streams into second-generation raw materials, particularly sustainable sugars, Twogee provides an alternative to fossil- and food-based feedstocks while supporting regional, circular value chains.

A key differentiator of Twogee’s approach is its licensing model, which enables local enzyme production directly at customer sites. This reduces transport-related emissions, improves supply chain resilience, and allows customers to operate more flexibly amid increasing global volatility.

Technology Built for Industrial Scale

Twogee integrates enzyme screening, strain engineering, and fermentation development within a single predictive system, reducing development timelines and minimizing scale-up risk. The company has already delivered multiple minimum viable products and completed paid pilot projects with industrial partners, validating both technical feasibility and commercial demand.

The company was founded by CEO Frank Wallrapp and CTO Helge Jochens, who together bring more than a decade of experience in industrial biotechnology. Supported by the BioM MAxL Incubator, Twogee operates in-house laboratories and bioreactors to accelerate projects from lab bench to industrial deployment.

Funding to Accelerate Commercialization

The new funding will be used to expand Twogee’s enzyme and strain portfolio, scale laboratory infrastructure, and support additional industrial partnerships.

“Many industrial residual streams contain significant untapped commercial value,” said Frank Wallrapp, CEO of Twogee Biotech. “We help our partners unlock this potential with minimal integration effort and a clear economic value proposition.”

Helge Jochens, CTO and co-founder, added: “A substantial portion of the funding will be invested in expanding our laboratories at the IZB with predictive bioreactor systems, as well as strengthening our team with experienced process and scale-up experts. This ensures our developments can be reliably transferred to customer production scale.”

Investor Perspectives

“At HTGF, we are very proud to invest in Twogee Biotech,” said Tilmann Petersen, Investment Manager at HTGF. “With its customer-specific enzyme technology, Twogee is enabling circular value creation across multiple downstream industries. Second-generation raw materials can become a true game changer when sustainability and profitability align.”

Monika Steger, Managing Director of Bayern Kapital, commented: “Twogee Biotech combines industrial biotechnology with a clear contribution to the circular economy by economically converting biological residues into high-value second-generation raw materials. This approach strengthens our life sciences portfolio in white biotechnology and shows strong potential for scalable impact.”

About Twogee Biotech

Headquartered in Martinsried, Munich, Twogee Biotech is an industrial biotechnology company focused on enabling circular, low-emission material flows for the chemical industry. By converting residual biomass into sustainable building blocks, the company helps partners reduce dependence on fossil feedstocks while unlocking new value from existing waste streams.

Media Contact
Twogee Biotech
info@twogee-biotech.com